von Känel Roland, Loredo José S, Ancoli-Israel Sonia, Mills Paul J, Natarajan Loki, Dimsdale Joel E
Department of General Internal Medicine, University Hospital Berne, Switzerland.
Medicine, University of California San Diego, La Jolla, CA.
Chest. 2007 Mar;131(3):733-739. doi: 10.1378/chest.06-2006.
Subjective sleep disturbances have been associated with increased risk of coronary artery disease (CAD). We hypothesized that disrupted sleep as verified by polysomnography is associated with increased levels of prothrombotic hemostasis factors previously shown to predict CAD risk.
Full-night polysomnography was performed in 135 unmedicated men and women (mean age +/- SD, 36.8 +/- 7.8 years) without a history of sleep disorders. Morning fasting plasma levels of von Willebrand Factor (VWF) antigen, soluble tissue factor (sTF) antigen, d-dimer, and plasminogen activator inhibitor (PAI)-1 antigen were determined. Statistical analyses were adjusted for age, gender, ethnicity, body mass index, BP, and smoking history.
Higher total arousal index (ArI) was associated with higher levels of VWF (beta = 0.25, p = 0.011, DeltaR(2) = 0.045), and longer wake after sleep onset was associated with higher levels of sTF (beta = 0.23, p = 0.023, DeltaR(2) = 0.038). More nighttime spent at mean oxygen saturation < 90% (beta = 0.20, p = 0.020, DeltaR(2) = 0.029) and higher apnea-hypopnea index (AHI) [beta = 0.19, p = 0.034, DeltaR(2) = 0.024] were associated with higher PAI-1. There was a trend for a relationship between mean oxygen desaturation < 90% and PAI-1 (p = 0.053), even after controlling for AHI. Total ArI (beta = 0.28, p = 0.005, DeltaR(2) = 0.056) and WASO (beta = 0.25, p = 0.017, DeltaR(2) = 0.042) continued to predict VWF and sTF, respectively, even after controlling for AHI.
Polysomnographically verified sleep disruptions were associated with prothrombotic changes. Measures of sleep fragmentation and sleep efficiency were related to VWF and sTF, respectively. Apnea-related measures were related to PAI-1. Our findings suggest that sleep disruptions, even in a relatively healthy population, are associated with potential markers of prothrombotic cardiovascular risk.
主观睡眠障碍与冠状动脉疾病(CAD)风险增加有关。我们假设,经多导睡眠图证实的睡眠中断与先前显示可预测CAD风险的促血栓形成止血因子水平升高有关。
对135名无睡眠障碍病史的未用药男性和女性(平均年龄±标准差,36.8±7.8岁)进行全夜多导睡眠图检查。测定早晨空腹血浆中血管性血友病因子(VWF)抗原、可溶性组织因子(sTF)抗原、D-二聚体和纤溶酶原激活物抑制剂(PAI)-1抗原的水平。统计分析对年龄、性别、种族、体重指数、血压和吸烟史进行了校正。
较高的总觉醒指数(ArI)与较高的VWF水平相关(β=0.25,p=0.011,ΔR²=0.045),睡眠开始后较长的觉醒时间与较高的sTF水平相关(β=0.23,p=0.023,ΔR²=0.038)。平均氧饱和度<90%的夜间时间更长(β=0.20,p=0.020,ΔR²=0.029)和较高的呼吸暂停低通气指数(AHI)[β=0.19,p=0.034,ΔR²=0.024]与较高的PAI-1相关。即使在控制AHI后,平均氧饱和度<90%与PAI-1之间仍存在关联趋势(p=0.053)。即使在控制AHI后,总ArI(β=0.28,p=0.005,ΔR²=0.056)和WASO(β=0.25,p=0.017,ΔR²=0.042)仍分别继续预测VWF和sTF。
经多导睡眠图证实的睡眠中断与促血栓形成变化有关。睡眠片段化和睡眠效率的指标分别与VWF和sTF有关。与呼吸暂停相关的指标与PAI-1有关。我们的研究结果表明,即使在相对健康的人群中,睡眠中断也与促血栓形成心血管风险的潜在标志物有关。